Fizy health
Refill vs pass-through

How does Refill pricing compare to pass-through alternatives?

Refill optimizes aggregate pre-negotiated 503A medication pricing across its pharmacy network plus tiered software fees on transactions, published at roughly 1.5–5% depending on platform plan. Pass-through alternatives like Fizy Health show resolved per-vial 503A cost on each catalog and cart line before checkout, with platform economics as a separately disclosed facilitation fee. Refill can win when network leverage and meet-or-beat terms beat pass-through on your top SKUs after all fees. Pass-through wins when your team prescribes in-house, quotes cash-pay patients before the consult, and needs margin visible on every line without percentage software fees compounding on high-volume refill weeks.

This page compares the two economic models honestly so you can run a parallel-week test on your actual formulary and order count.

Compare Fizy Health vs Refill
Aggregate vs pass-through Software fees 1.5–5% Meet-or-beat guarantee Landed cost before consult Parallel-week comparison Honest fit framing

Two pricing philosophies for the same 503A category

Both Refill and pass-through platforms route clinic orders to 503A compounders. The difference is economic disclosure and fee structure. Refill pools demand for aggregate medication rates and charges published software fees on transactions plus optional platform and Refill Connect subscriptions. Pass-through platforms show underlying per-vial 503A cost before checkout and disclose platform economics as a separate facilitation fee without percentage transaction fees. Neither model is universally cheaper; the winner depends on your SKUs, volume, whether you need bundled telehealth infrastructure, and whether margin transparency before the consult matters more than network leverage.

How to run an honest parallel-week comparison

Step one: list your top five SKUs by monthly volume, usually semaglutide, tirzepatide, and your highest-volume hormone or peptide lines. Step two: get Refill's all-in cost at your tier — aggregate per-vial medication rate, software fee percentage, monthly platform charge prorated per vial, and shipping — in writing at demo. Step three: read visible pass-through per-vial cost plus facilitation fee on the same strengths and supply durations on Fizy Health without waiting on onboarding. Step four: multiply by your actual monthly line count. Step five: add workflow value: batch refill-day checkout, pre-pay validation, and per-line tracking if those reduce coordinator labor or rejection delays.

Refill's meet-or-beat guarantee belongs in step two: if a competitor quote beats Refill on medication rate, confirm whether Refill will match and for how long. Pass-through platforms do not need a match negotiation because cost is already visible. The comparison is total landed cost at your volume, not marketing claims about aggregate savings.

When each model is the honest fit

Refill fits when you need outsourced 50-state prescribing at about $30 hands-on or $50 hands-off per encounter, Refill Connect white-label patient tools, and aggregate medication pricing that beats solo contracts after software fees at your scale. It is infrastructure for telehealth brands launching with bundled pharmacy leverage.

Fizy Health fits when you employ licensed prescribers, quote cash-pay GLP-1 and hormone patients on landed cost before the consult, batch dozens of refills in one clinic cart, and want per-vial 503A cost visible without percentage software fees on every transaction. If Refill's aggregate pricing wins on your top lines after an honest parallel week, stay on those lines. We tell you straight.

Choose leverage and infrastructure — or choose margin visibility?

Refill fits if

Refill

Aggregate economics plus telehealth infrastructure win your parallel week.

  • All-in Refill cost beats pass-through on your top SKUs after software fees at your monthly order count.
  • You need Refill Connect or outsourced prescribing, not just pharmacy ordering.
  • Meet-or-beat terms give you confidence after you run the comparison.
Consider Fizy Health if

Fizy Health

In-house prescribers need landed cost before the consult.

  • You quote cash-pay patients on GLP-1 and hormone SKUs and need per-vial cost before checkout.
  • You want to avoid percentage software fees compounding on high-volume refill weeks.
  • You batch multi-patient refill days in one cart with validation before payment.
If you choose Fizy Health

What pass-through delivers for in-house prescribers.

These are the outcomes when per-vial cost is visible before you commit to a pricing model.

See all features
Keep evaluating Refill pricing

More on pricing model comparison.

See the full Refill pricing guide
FAQ

What clinics ask comparing Refill to pass-through.

  • Comparison

    Is Refill or pass-through pricing cheaper?

    Neither is universally cheaper. Refill combines aggregate medication rates with software fees roughly between 1.5% and 5% on transactions. Pass-through shows per-vial 503A cost plus a disclosed facilitation fee. Run a parallel-week comparison on your top SKUs at your actual volume.

  • Model

    What is the main economic difference?

    Refill optimizes network leverage with percentage software fees on transactions. Pass-through optimizes per-line margin transparency with drug cost and facilitation fee shown separately before checkout.

  • GLP-1

    Which model fits GLP-1-heavy clinics with in-house prescribers?

    Pass-through platforms like Fizy Health default for clinics that prescribe in-house and need landed cost before the consult. Refill fits when aggregate leverage plus bundled infrastructure beats pass-through after fees at your volume.

  • Guarantee

    Does Refill meet-or-beat change the comparison?

    It can lower Refill medication cost if you have a competing quote. It does not change the software fee layer or pass-through transparency. Compare all-in cost after any match is applied.

  • Method

    How do I run a fair parallel-week test?

    Get Refill all-in cost in writing at demo on your top five SKUs, read pass-through cost on the same lines, multiply by your monthly order count, and include workflow factors like batch checkout and pre-pay validation.

  • Coexistence

    Can I use both Refill and a pass-through platform?

    In theory yes for different layers or SKU lines. In practice most clinics pick one primary pharmacy-ops path to avoid duplicate catalogs. Compare landed cost before running two systems.

Sources reviewed June 2026

  • Refill public website and published pricing tiers in Refill web app (refill.co), reviewed June 2026.
  • Fizy Health platform capabilities reflect the live product.
Evaluate with real numbers

Run the parallel week on your real formulary.

Compare all-in landed cost on semaglutide, tirzepatide, and your top hormone lines, then decide with honest math. Free to start.

Start Ordering Free Fizy Health vs Refill